country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-163039

Copy Link Print Information

DOTA-biotin

DOTA-biotin is a bifunctional molecule formed by conjugating the chelator DOTA with biotin. The DOTA group of DOTA-biotin can form extremely stable complexes with a variety of radioactive metal nuclides, while the biotin group exhibits highly specific binding affinity for avidin or streptavidin. DOTA-biotin possesses rapid blood clearance activity and minimal systemic and non-target organ retention. DOTA-biotin can be used for cancer research.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

CAS No.: 188428-79-7
Formule: C₃₆H₅₄N₈O₁₁S
Masse moléculaire:806.93

Stockage:

Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month

Data Sheet (269 KB)

DOTA-biotin Chemical Structure

CAS No.: 188428-79-7

Stock

Quantité

Amount: USD 0.00

* Veuillez sélectionner la quantité avant d'ajouter des articles.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Activité biologique
- Description
- In Vitro
Chemical Information
Pureté et documentation
Références
Calculators
Help & FAQs
Classifications
Bioz

Activité biologique

Description

In Vitro

DOTA-biotin efficiently chelates ¹⁷⁷Lu, ⁹⁰Y, or ¹¹¹In in in vitro radionuclide labeling reaction systems to form stable radioactive complexes^[3].
DOTA-biotin (20 min) is efficiently labeled with ⁶⁸Ga at a radiochemical purity of > 97% in the copper-free click chemistry and ⁶⁸Ga labeling system in vitro^[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Related Protocols :

Protocol for Pharmacokinetic Study

Chemical Information

CAS No. 188428-79-7
Appearance Solid
Masse moléculaire 806.93
Formule C₃₆H₅₄N₈O₁₁S
Color White to light yellow
SMILES

OC(CN(CCN(CCN(CCN(C1)CC(O)=O)CC(O)=O)CC(O)=O)C1CC(C=C2)=CC=C2NC(CN(C)C(CCCC[C@H]3[C@]4([H])[C@](NC(N4)=O)([H])CS3)=O)=O)=O
Livraison

Room temperature in continental US; may vary elsewhere.

Stockage

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Pureté et documentation

Select Batch:

Pureté: 99.98%

Assay: 99.98%

ee.: 99.98%

Fiche technique (269 KB)
SDS (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Instruction de manipulation (2659 KB)

Références

[1]. Pratesi A, et al. Biotin derivatives carrying two chelating DOTA units. Synthesis, in vitro evaluation of biotinidases resistance, avidin binding, and radiolabeling tests. Journal of medicinal chemistry. 2010 Jan 14;53(1):432-40.

[2]. Orcutt KD, et al. Biodistribution and clearance of small molecule hapten chelates for pretargeted radioimmunotherapy. Molecular imaging and biology. 2011 Apr;13(2):215-21. [Content Brief]

[3]. Breitz HB, et al. Clinical optimization of pretargeted radioimmunotherapy with antibody-streptavidin conjugate and 90Y-DOTA-biotin. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2000 Jan;41(1):131-40.

[4]. Schultz MK, et al. Synthesis of a DOTA--biotin conjugate for radionuclide chelation via Cu-free click chemistry. Organic letters. 2010 May 21;12(10):2398-401.

Calculators

Calculateur de molarité

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Calculateur de dilution

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Obtenir un devis En stock

Other size

Obtenir un devis